Want to see SG:569 full AI Analyst Report?
569 Stock Chart & Stats
S$0.08
S$0.00(0.00%)
At close: 4:00 PM EDT
S$0.08
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.10
Previous CloseN/A
Volume4.90K
Average Volume (3M)97.25K
Market Cap
S$39.35M
Enterprise ValueS$78.28M
Total Cash (Recent Filing)S$6.51M
Total Debt (Recent Filing)S$43.91M
Price to Earnings (P/E)―
Beta0.51
Next Earnings
Sep 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding511,537,700
10 Day Avg. Volume66,350
30 Day Avg. Volume97,253
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.65
Price to Sales (P/S)0.39
P/FCF Ratio-7.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound In 2025A 44.7% top-line rebound in 2025 indicates renewed demand and the company’s ability to regain lost sales. If sustained, higher revenue improves operating leverage, helps absorb fixed costs, and is a durable driver for restoring profitability and cash generation over the next several quarters.
High Gross Margins (~51–55%)Consistently high gross margins imply durable product-level pricing power or efficient production. This margin buffer increases the odds that the company can return to net profitability as operating expenses normalize, preserving long-term margin sustainability across cycles.
Sizable Equity Cushion (~S$71–79m)A meaningful equity base provides a capital buffer to absorb losses and supports liquidity through downturns. This structural balance-sheet strength gives management flexibility to pursue working capital, investment, or restructuring actions without immediate solvency pressure.
Bears Say
Shift To Net Losses In 2024–2025Transitioning from multi-year profitability to net losses is a structural concern: it erodes retained earnings, depresses return metrics, and limits organic reinvestment. Without sustainable margin recovery, the company will struggle to rebuild capital and competitiveness over the medium term.
Weak Operating Cash Flow And Negative Free Cash FlowMaterial weakening of cash generation undermines funding flexibility: near-zero operating cash flow and persistent negative FCF force reliance on external financing, constrain capex and R&D, and raise refinancing risk if losses continue, creating durable pressure on growth plans.
Rising Leverage (debt-to-equity ~0.58)Increasing debt relative to equity reduces financial flexibility and raises fixed interest obligations. In combination with weak cash flow and recent losses, higher leverage elevates solvency and refinancing risks and may force deleveraging or equity raises that dilute shareholders.
VicPlas International Ltd. News
569 FAQ
What was VicPlas International Ltd.’s price range in the past 12 months?
VicPlas International Ltd. lowest share price was S$0.07 and its highest was S$0.10 in the past 12 months.
What is VicPlas International Ltd.’s market cap?
VicPlas International Ltd.’s market cap is S$39.35M.
When is VicPlas International Ltd.’s upcoming earnings report date?
VicPlas International Ltd.’s upcoming earnings report date is Sep 25, 2026 which is in 55 days.
How were VicPlas International Ltd.’s earnings last quarter?
VicPlas International Ltd. released its earnings results on Mar 13, 2026. The company reported -S$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.007.
Is VicPlas International Ltd. overvalued?
According to Wall Street analysts VicPlas International Ltd.’s price is currently Overvalued.
Does VicPlas International Ltd. pay dividends?
VicPlas International Ltd. pays a Annually dividend of S$0.004 which represents an annual dividend yield of N/A. See more information on VicPlas International Ltd. dividends here
What is VicPlas International Ltd.’s EPS estimate?
VicPlas International Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VicPlas International Ltd. have?
VicPlas International Ltd. has 511,537,700 shares outstanding.
What happened to VicPlas International Ltd.’s price movement after its last earnings report?
VicPlas International Ltd. reported an EPS of -S$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.124%.
Which hedge fund is a major shareholder of VicPlas International Ltd.?
Currently, no hedge funds are holding shares in SG:569
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VicPlas International Ltd.
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Republic of China, and the United Kingdom. Its piping division focuses on the manufacturing, trading, and distribution of a variety of piping solutions. These systems are utilized for diverse applications such as waste and potable water management in residential, educational, commercial, and industrial settings; conduits for underground electrical and internal building wiring; and data and signal lines for telecommunication providers. Additionally, Vicplas is engaged in the design, development, production, and assembly of both sterile and non-sterile medical devices. The company also offers specialized project design and engineering services. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
Technical Analysis
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
AJJ Medtech Holdings Limited
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―